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ABSTRACT 
Objective: This study evaluates the registration status and the quality of nine brands of Vitamin C sold in Freetown, Sierra Leone, using official and 
non-official methods of analysis.  
Methods: The parameters taken into consideration during the study include non-official methods (friability and disintegration) and the official 
methods (identification test, uniformity of dosage unit, and assay by titrimetric and colorimetric tests). The different brands of vitamin C were 
selected and classified as registered and unregistered based on the data derived from the National Medicines Regulatory Authority.  
Results: One vitamin C product collected was unregistered at the National medicines regulatory authority (Pharmacy Board of Sierra Leone). All 
nine vitamin C products met the requirements for uniformity of dosage unit. The vitamin C products also conformed to the BP specification for 
friability and identification test (retention factor). The identification test showed that each brand contained vitamin C (ascorbic acid). The 
disintegration test was not applicable for chewable tablets. Three of the four non-chewable vitamin C products complied with the BP specification 
for disintegration, while one failed and did not meet the requirement. The assay results for ascorbic acid using titration and colourimetric method 
were comparable and appropriate for determining vitamin C. Out of a total of nine samples; seven met the requirement for BP specification (Passed) 
for assay. In contrast, one product did not meet the BP requirement (failed), and one sample had more vitamin C than the Pharmacopoeia limit.  
Conclusion: Periodic quality evaluation and routine checks for pharmaceutical products can ascertain the quality of products, their storage 
conditions and identify potential counterfeit medications. 
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INTRODUCTION 
Vitamin C or L-ascorbate is a water-soluble vitamin. It is a vital 
antioxidant that plays an essential role in human nutrition [1]. It acts 
as a cofactor for some biologically active radicals. Vitamin C is 
necessary for building blood vessels, ligaments, tendons, bones and 
is also essential in synthesising carnitine, which is involved in 
metabolism in most plants and some bacteria [1, 2].  
WHO suggested that most drugs in the world today are either 
falsified or substandard and that 10% are from low and middle-
income countries. Substandard medicines may come from poor 
manufacturing and quality assurance processes and reach the public 
due to lax control measures, whereas falsified medicines are 
deliberately and fraudulently labelled [3].  
Ascorbic acid degrades in the presence of enzymes and atmospheric 
oxygen [4]. Vitamin C bears an obvious similarity with hexose sugars; 
hence it is conceivable that the molecule might serve as a carbon 
source for respiration or bacteria growth that might be fermented [5]. 
Storage condition of low temperature and humidity retards microbial 
growth whereby chemical and biological processes are slowed down 
[6]. However, breaching the protective barrier by microbial growth 
results in the subsequent destruction of the commodity.  
An excellent quality control system can create the platform for 
employers and employees to develop a fantastic working 
atmosphere and efficiency resulting from improved wellbeing and 
quality of life achieved by preventing absence from work and 
reducing hospital stay. This study adds to research evidence in 
Sierra Leone and the African region by providing information for 
researchers and the public on the quality of vitamin C products 
circulating in Sierra Leone. It also includes rudimentary information 
on the registration status of the sampled vitamin C products. 
MATERIALS AND METHODS 
Experimental design 
The convenience sampling of nine (9) brands of vitamin C, 
purchased and collected from Pharmacies in Freetown from the 
20th February to the 22nd March 2019 and stored using the 
recommendations on each label claim. The physicochemical analysis 
at the National Pharmaceutical Quality Control Laboratory of the 
Pharmacy Board of Sierra Leone, New England Ville, Freetown, took 
place from the 20th to the 2nd June 2019. 
Test solution, solvent, and reagents 
0.1M Ammonium cerium (IV) Sulphate, 1M H2SO4, 
Instrument used 
water, ferroin 
solution, ethanol, ferricyanide solution. 
The instrument includes Analytical balance, volumetric Flask, 
friabulator, vernier calliper, filter paper, separating funnel, pipette, 
mortar, pestle, weighing boat, timer, measuring cylinder, burette, 
burette stand, UV lamp, UV apparatus, Thin layer chromatography 
chamber, Thin layer Chromatography plate, chromatogram. 
Test methods used 
Active substance identification test 
Thin Layer Chromatography Identification: Thin layer 
Chromatogram of pure vitamin C (0.5%) in water and equivalents 
solutions of tablets obtained with Ethanol-EtOH: Water-H2O (6:1) as 
a solvent system using their Rf
Uniformity of dosage units 
 values and colour characteristics 
under ultraviolet light [2, 7]. 
Weighed ten tablets individually using an analytical balance. The 
weight of the ten (10) tablets is determined to calculate the average 
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weight. The assay value for each tablet was determined using the 
average weight. The acceptance criteria were determined using the 
method in the British Pharmacopoeia 2018 [7]. 
Disintegration test 
The requirement for disintegration does not apply to Chewable 
Ascorbic Acid Tablet. One dosage unit was placed in each of the 
basket's six tubes and added a disc. The apparatus, operated using 
the specified medium of 37 °C as the immersion fluid. The time taken 
for each of the four tablets of each brand to disintegrate was 
recorded [7]. 
Friability 
Twenty tablets were weighed and subjected to abrasion for 4 min at 
100 rev/min using Erweka single drum friability tester. The end of 
the revolution was then followed by reweighing the twenty tablets 
to calculate the percentage loss.  
If cracked, cleaved, or broken tablets are present in the tablet 
sample after tumbling, it fails the test. If the results are difficult to 
interpret or the weight loss is greater than the targeted value, the 
test procedure was rechecked and repeated, and the mean of three 
tests, determined. A maximum weight loss (obtained from a single 
test or the average of three tests) of not more than 1.0% is 
considered acceptable for most products. 
For each brand of Vitamin C tablets, a tablet sample was carefully 
dusted, weighed (W1), and placed in the friabulator at 100rpm 
(rounds per minute) for four minutes. At the end of the four minutes, 
the tablets are removed from the drum, dusted, and accurately 
weighed for the second time (W2) [7]. 
Percentage of Friability of ascorbic acid was determined using the 
formula below:  
Percentage Friability = �
Initial weight (W1)−Final weight (W2)
Initial weight (W1) �
× 100 
Assay by titrimetry 
Twenty tablets are weighed together and powdered. A quantity 
containing 0.15g of ascorbic acid was dissolved in a mixture of 30 ml 
of water and 20 ml of 1M Sulphuric acid and titrated with 0.1M 
Ammonium Cerium (IV) Sulphate, using ferroin solution as the 
indicator [7]. 
Assay by colourimetric method 
The absorbance of the coloured complex formed between potassium 
ferricyanide solution and ascorbic acid measured at 520 nm was 
used to plot a calibration curve against the concentration of ascorbic 
acid (2.5-25ug/ml}. The amount of ascorbic acid was determined 
using the regression equation from the calibration curve [2]. 
 
RESULTS 
Profile of vitamin c tablets 














001 Orange cylindrical 
tablet with a line on 








India Store at temperature 
below 25 °C protected 
from light and 
moisture 
100 mg Registered 
002 Orange flavour oval 
tablets 







Store in a cool, dry 
place 
500 mg Registered 
003 Orange cylindrical 
tablet with a line on 
the centre of one 









Nigeria Store in a cool, dry 
place below 30 °C 
100 mg Registered 
004 Orange cylindrical 








Nigeria Store in a cool, dry 
place protected from 
light 
100 mg Registered 
005 Brown cylindrical 
tablet 







USA Store at room 
temperature, tightly 
closed 
500 mg Registered 
006 Yellow cylindrical 
tablet with a line on 
the centre of one 
side 






China Store in a cool, dry 
place. Keep out of 
reach of children 
100 mg Registered 
007 Lemon yellow 
cylindrical tablet 





China Store in a cool, dry 
place below 30 °C 
250 mg Unregistered 
008 Orange cylindrical 
tablet 






Nigeria Store in a cool and dry 
place 
100 mg Registered 








Nigeria Store in a cool, dry 
place below 25 °C. 
Protect from light and 
moisture and keep out 
of reach of children. 
100 mg Unregistered 
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Mean, standard deviation and acceptance value of vitamin C 
Table 2: Uniformity of dosage units this shows the deviation and acceptance value for each sample of ascorbic acid tablets. Sample 002 did 
not meet the requirement for acceptance value 
Sample Mean±SD1 Calculated 




acceptance value 2 
Acceptance limit(L2); lower, 
upper limit 
001 106.3±1.70 8.84 ≤15 NA NA NA 
002 115.1±1.03 16.04 ≤15 115.06±0.81 15.18 ≤25; 86.30,143.83 
003 100.9±0.48 1.72 ≤15 NA NA NA 
004 101.6±1.80 4.48 ≤15 NA NA NA 
005 102.7±1.78 5.418 ≤15 NA NA NA 
006 100.4±2.32 6.698 ≤15 NA NA NA 
007  100.2±1.30 3.742 ≤15 NA NA NA 
008 52.6±1.09 2.568 ≤15 NA NA NA 
009 101.5±3.48 9.623 ≤15 NA NA NA 
NA: Not Applicable; ne (number of experiments for each sample) = 10; SD = standard deviation 
 
Identification and friability test for vitamin c 
Table 2: Identification and Friability test for vitamin C the samples showed the same retention factor (Rf
Sample 
) for each brand of ascorbic acid. 
Friability percentage calculated to determine the physical strength of compressed and uncoated tablets showed that each tablet had less 
than 1 % breakage 
Friability (%)±SD Rf Values 
001 99.85±0.01 0.7 
002 99.75±0.05 0.7 
003 99.73±0.05 0.7 
004 99.69±0.07 0.7 
005 100±0.35 0.7 
006 99.91±0.02 0.7 
007 98.2±0.30 0.7 
008 99.30±0.05 0.7 
009 99.62±0.03 0.7 
NA: Not Applicable; ne (number of experiments for each sample) = 3; SD = standard deviation 
 
Disintegration test for vitamin C 
Table 3: Disintegration test for non-chewable vitamin C tablet, the requirement for disintegration does not apply to chewable tablets. All 
samples tested met the requirement for disintegration, while sample 003 did not comply with the requirement for disintegration as per 
the British pharmacopoeia 
Sample code Time (min) Limit 
001 NA Not Applicable for Chewable Tablets 
002 NA Not Applicable for Chewable Tablets 
003 30 <15 min 
004 NA Not Applicable for Chewable Tablets 
005 NA Not Applicable for Chewable Tablets 
006 NA Not Applicable for Chewable Tablets 
007 5 <15 min 
008 6 <15 min 
009 7 <15 min 
NA: Not applicable 
 
Assay of vitamin C  
Table 4: Assay of vitamin C tablet, six samples (003, 004, 005, 006, 007, and 009) met the requirement for BP pharmacopoeia, while two 
samples (001 and 002) recorded more significant quantities of vitamin C for one or both quality control analysis (titrimetry and 
colourimetry) and one sample (008) failed quality control analysis 
Sample code Titration value (%) Colorimetric (%) Limit (%) 
001 106.27 110.00 95.00-107.50 
002 115.07 >125.00 95.00-107.50 
003 100.74 95.00 95.00-107.50 
004 101.56 100.00 95.00-107.50 
005 103.40 106.25 95.00-107.50 
006 100.13 100.00 95.00-107.50 
007 100.74 103.75 95.00-107.50 
008 52.42 47.50 95.00-107.50 
009 102.99 100.00 95.00-107.50 
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DISCUSSION 
This study evaluates the different brands of vitamin C (ascorbic 
acid) in Freetown using the following methods: thin layer 
chromatography test, uniformity of dosage unit, assay to determine 
the content of active pharmaceutical ingredients in the 
pharmaceutical tablet, colourimetric method, friability, and 
disintegration test [8]. 
The sample profile in table 1 describes the different brands of 
Vitamin C based on packaging, manufacturing country, storage 
condition, and the strength of ascorbic acid used. The uniformity of 
the dosage unit [8] for determining the consistency in the amount of 
ascorbic acid for each brand of vitamin C. Sample 2 was outside the 
required limit for the first assessment but was within the accepted 
limit for the second assessment. Therefore, all the samples in this 
study met the deviation and acceptance values as per the British 
Pharmacopoeia 2018.  
The retention factor (Rf) of 0.7 for identification of pure vitamin C 
showed that all the different brands of vitamin C contained ascorbic 
acid. A study conducted in India also used the retention factor as a 
method for the identification of active ingredients [9]. In addition, a 
2008 study conducted in Nigeria also showed that pure ascorbic acid 
or vitamin C brands had an Rf value of 0.7 [2]. 
Friability test for all the samples gave a weight loss of<1% revealing 
that all the samples complied with the BP (2018) specification and 
that these brands can withstand abrasion without loss of integrity. 
This friability result is similar to a study conducted in Bangladesh in 
which most of the samples passed the standard limit of friability 
(Not more than 1%) [10]. 
The disintegration test (non-official method) done on the four 
brands of non-chewable tablets showed that three of the brands 
complied with the specification of less than 15 min for disintegration 
time while one of the brands failed the disintegration test. The 
disintegration test does not apply to chewable tablets BP 2018 [7]. 
The ability of the three brands to disintegrate within this time 
indicates that these tablets can break down in the gastrointestinal 
tract and release their content into the systemic circulation. This 
result is similar to a study conducted in Nigeria for determining the 
disintegration rates in which disintegration time ranged from 0.32 
to 24.03 min, and all the disintegration times were within the BP 
official limit of 30 min [11]. 
The assay results for ascorbic acid using titrimetric and 
colourimetric methods for all the samples were comparable. The 
results showed that the titration value and colourimetric value for 
the ascorbic acid were consistent, indicating that each technique is 
appropriate for determining ascorbic acid. This result means that 
there was little or no interference of the excipient on the assay 
procedure [12]. Seven out of the nine brands were within the official 
titration specification of 95.0-107.50% BP (2018). One sample had 
more than the required active ingredient, possibly because of the 
addition of overages to vitamins by most manufacturers [13]. One 
brand failed both titrimetric and colourimetric analysis, maybe due 
to poor storage at the pharmaceutical outlet or poor handling during 
transportation from manufacturer to the point of sale or use. 
Research evidence in Bangladesh showed poor pharmaceutical 
practices in pharmacies of Bangladesh and confirmed that the 
regulatory authority has a vital role to play in shaping the behaviour 
of pharmacies [14]. 
This study has shown a need for functional evaluation of the quality 
of drugs in the supply chain through robust pre-and post-market 
surveillance measures to identify substandard and deteriorated 
drugs. Furthermore, in ascertaining the quality of different brands of 
medicine, assay for active constituents should be combined with 
assessment of other pharmaceutical parameters that include storage 
conditions and the suitability of the facilities handling the products 
and personnel. 
Our study did not determine the storage condition of the different 
pharmaceutical outlets. However, this study provided information 
on the quality of vitamin C and their registration status despite this 
limitation. It also showed the need for wide-scale post-market 
research to understand the effect of environmental conditions on 
drugs and their drug deterioration in the supply chain in different 
parts of the country. 
CONCLUSION 
Our study confirmed that one of the nine vitamin C products 
assessed was unregistered. Also, our findings showed that one of the 
nine registered samples did not contain the required content of 
Vitamin C. Our results emphasised the need for pharmaceutical 
wholesalers and retailers to follow the shelf-life storage 
recommendations of the manufacturer. The study provides good 
insight into the importance of conducting routine quality evaluation 
through post-market surveillance and the need to ascertain good 
pharmaceutical practice, including good storage and identification of 
potential substandard and counterfeit medications. 
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